Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-19

Clinical Trial Update: Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized controlled trial evaluating frequency and intensity of local reactions to 4% 5-FU alone versus 4% 5-FU with an emollient cream in actinic k…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-FU 4% (5-fluorouracil)
  • 5-FU 4% with emollient cream

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Actinic Keratoses | Phase 4 | Status: COMPLETED